BACKGROUND	Boceprevir represents a new treatment option for hepatitis C ( HCV ) - infected patients , including those with HCV/human immunodeficiency virus coinfection ; however , little is known about pharmacokinetic interactions between boceprevir and antiretroviral drugs .\